Brief: MEI Pharma Reports First Quarter Fiscal Year 2023 Results
14/11/2022 21:21
Nov 14 (Reuters) - MEI Pharma Inc MEIP.O :
* MEI PHARMA REPORTS FIRST QUARTER FISCAL YEAR 2023 RESULTS
AND
OPERATIONAL HIGHLIGHTS
* MEI PHARMA INC-QTRLY REVENUE $8.7 VERSUS $7.8 MILLION FOR
QUARTER ENDED SEPT 30, 2021
* MEI PHARMA INC Q1 LOSS PER SHARE $0.12
Source text for Eikon: ID:nBw35kPbda
Further company coverage: MEIP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations